News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
ARCH Venture Fund VII, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/22/2020 |
4
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on 908 Devices Inc.|
Txns:
| Converted 5,425,045 shares
@ $0
Bought 300,000 shares
@ $20, valued at
$6M
Converted 2,927,386 preferred shares
@ $0
Converted 981,443 preferred shares
@ $0
Converted 669,977 preferred shares
@ $0
Converted 665,661 preferred shares
@ $0
Converted 180,578 preferred shares
@ $0 |
|
| 07/17/2019 |
4
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 2,700 shares
@ $8.2651, valued at
$22.3k
Sold 25,779 shares
@ $7.8078, valued at
$201.3k
Sold 34,521 shares
@ $7.6964, valued at
$265.7k
|
|
| 03/14/2019 |
4
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 40,092 shares
@ $7.3674, valued at
$295.4k
Sold 81,591 shares
@ $7.8862, valued at
$643.4k
Sold 2,820 shares
@ $8.1993, valued at
$23.1k
Sold 43,000 shares
@ $8.1498, valued at
$350.4k
|
|
| 03/11/2019 |
4
| ARCH Venture Fund VII, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Sold 35,209 shares
@ $6.8736, valued at
$242k
Sold 84,496 shares
@ $6.9266, valued at
$585.3k
Sold 44,878 shares
@ $6.4924, valued at
$291.4k
|
|
| 11/06/2018 |
4
| ARCH Venture Partners VIII, LLC (10% Owner) has filed a Form 4 on Twist Bioscience Corp|
Txns:
| Converted 1,182,645 shares
@ $0
Converted 718,275 shares
@ $0
Converted 266,776 shares
@ $0
Converted 224,726 shares
@ $0
Bought 15,000 shares
@ $14, valued at
$210k
Converted 894,146 shares
@ $0
Bought 60,000 shares
@ $14, valued at
$840k
Converted 1,182,645 preferred shares
@ $0
Converted 718,275 preferred shares
@ $0
Converted 266,776 preferred shares
@ $0
Converted 224,726 preferred shares
@ $0 |
|
| 05/07/2018 |
4
| ARCH Venture Partners VII, LLC (10% Owner) has filed a Form 4 on Unity Biotechnology, Inc.|
Txns:
| Converted 2,030,625 shares
@ $0
Converted 4,228,432 shares
@ $0
Converted 2,067,160 shares
@ $0
Converted 1,486,745 shares
@ $0
Converted 195,672 shares
@ $0
Converted 2,030,625 preferred shares
@ $0
Converted 4,228,432 preferred shares
@ $0
Converted 2,067,160 preferred shares
@ $0
Converted 1,486,745 preferred shares
@ $0
Converted 195,672 preferred shares
@ $0 |
|
| 04/12/2018 |
4
| Arch Venture Fund VII LP (Former 10% Owner) has filed a Form 4 on Pulmatrix, Inc. |
| 04/05/2018 |
4
| GILLIS STEVEN (Director) has filed a Form 4 on Pulmatrix, Inc.|
Txns:
| Bought 1,150,000 shares
@ $0
Bought 1,150,000 options to buy
@ $0.65, valued at
$747.5k
Bought 1,150,000 options to buy
@ $0.75, valued at
$862.5k
|
|
| 07/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/31/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/26/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|